PharmEasy’s Parent Company API Holdings Plans Rs 2,000 cr-Rs 3,000 cr Rights Issue

  • API Holdings aims to repay its debt through this rights issue and additional investment from Manipal Group.
  • API had previously borrowed $285 million from Goldman Sachs to pay off former debt, pledging shares of subsidiary Thyrocare as collateral.
  • The post-money valuation of the company after this funding initiative is expected to be between Rs 6,000 to Rs 7,000 crore.
Join 2 million subscribers

A curated newsletter that summarizes the important news at the intersection of Global tech, India Tech and AI.

Delivered 8 AM. Daily.
nextbigwhat We would like to show you notifications for the latest news and updates.
Allow Notifications